New Research Highlights 'Bad Reasoning' in LLM Clinical Trial Analysis
A new study identifies flaws in how LLMs handle clinical trial data, proposing a hybrid approach to improve reasoning. The research focuses on recovering implicit attributes from partially observed tables.
Researchers have identified significant reasoning gaps in how large language models (LLMs) process clinical trial data. The study, published on arXiv, highlights that current LLM approaches often suffer from "bad reasoning" when dealing with implicit planning assumptions. This includes struggles to recover implicit attributes such as therapy type, added agents, endpoint roles, or follow-up status from partially observed clinical-trial tables.
The research underscores the importance of semantic understanding in clinical trial table reasoning, where answers are not directly stored in visible cells but must be inferred through normalization, classification, extraction, or lightweight domain reasoning. This is particularly crucial for accurate diagnosis and treatment planning. The study proposes a hybrid approach to mitigate these issues, combining the strengths of LLMs with structured data processing techniques.
The findings suggest a need for improved models that can handle the complexity of clinical trial data more effectively. Future research may focus on developing more robust reasoning frameworks and integrating them into existing healthcare systems. The study also raises questions about the reliability of current AI tools in medical diagnostics and treatment planning.